ATE148992T1 - Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen - Google Patents

Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen

Info

Publication number
ATE148992T1
ATE148992T1 AT90917939T AT90917939T ATE148992T1 AT E148992 T1 ATE148992 T1 AT E148992T1 AT 90917939 T AT90917939 T AT 90917939T AT 90917939 T AT90917939 T AT 90917939T AT E148992 T1 ATE148992 T1 AT E148992T1
Authority
AT
Austria
Prior art keywords
molecular weight
tnf
compositions
convertase
inhibiting protein
Prior art date
Application number
AT90917939T
Other languages
English (en)
Inventor
Michael P Kriegler
Carl F Perez
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE148992T1 publication Critical patent/ATE148992T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90917939T 1989-08-16 1990-06-08 Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen ATE148992T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39525389A 1989-08-16 1989-08-16

Publications (1)

Publication Number Publication Date
ATE148992T1 true ATE148992T1 (de) 1997-03-15

Family

ID=23562283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90917939T ATE148992T1 (de) 1989-08-16 1990-06-08 Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen

Country Status (9)

Country Link
EP (2) EP0750037A3 (de)
JP (1) JP2930713B2 (de)
AT (1) ATE148992T1 (de)
AU (2) AU5940090A (de)
CA (1) CA2020700A1 (de)
DE (1) DE69029970T2 (de)
DK (1) DK0491878T3 (de)
ES (1) ES2097766T3 (de)
WO (1) WO1991002540A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
EP0592423B1 (de) * 1990-08-06 2000-11-15 Chiron Corporation Verfahren zum nachweis von cytokinkonvertasehemmern
JP3534748B2 (ja) * 1991-07-05 2004-06-07 ペプテック リミテッド Ｔｎｆ及び／またはｌｐｓ毒性を抑制するペプチド
US6348327B1 (en) * 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
EP0648225A1 (de) * 1992-06-25 1995-04-19 Chiron Corporation Zusammensetzungen zur inhibition der bildung von proteinhormonen und anwendungen davon
UA41338C2 (uk) * 1992-09-09 2001-09-17 Амген Інк. Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
WO1995024501A1 (en) 1994-03-07 1995-09-14 Cetus Oncology Corporation Compositions for the inhibition of tnf formation and uses thereof
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
EP0830130B9 (de) * 1995-06-08 2004-12-29 Immunex Corporation Tnf-alpha konvertierendes enzym
US5830742A (en) * 1995-06-08 1998-11-03 Immunex Corporation TNF-α converting enzyme
CN1310675C (zh) * 1995-07-20 2007-04-18 依默耐克斯有限公司 TNF－α转变酶
US5853977A (en) 1996-07-12 1998-12-29 Schering Corporation Mammalian TNF-α convertases
US6180402B1 (en) 1996-11-20 2001-01-30 Qlt Inc. Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB867679A (en) 1958-10-06 1961-05-10 Allied Chem Improved process for the preparation of hydrogen peroxide
GB1158829A (en) 1967-08-04 1969-07-23 Ifa Getriebewerke Brandenburg Shift Mechanism for Overdrive Arrangements
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPH0695939B2 (ja) 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
EP0148311B1 (de) 1983-12-26 1988-07-20 Asahi Kasei Kogyo Kabushiki Kaisha Physiologisch aktives Polypeptid
EP0155549B1 (de) 1984-03-06 1991-03-20 Dainippon Pharmaceutical Co., Ltd. DNS den menschlichen Tumornekrosisfaktor kodierend und das menschliche Tumornekronisfaktor-Polypeptid
US4879226A (en) 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
GR851626B (de) 1984-07-05 1985-11-26 Genentech Inc
FI853395L (fi) 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
US4677064A (en) 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4677063A (en) 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
EP0200748B1 (de) 1984-10-15 1991-02-06 Cetus Corporation Menschlicher tumornekrosisfaktor
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor
GB8806339D0 (en) * 1988-03-17 1988-04-13 Hoffmann La Roche Monoclonal antibodies
WO2000024941A1 (en) 1998-10-27 2000-05-04 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes

Also Published As

Publication number Publication date
DE69029970T2 (de) 1997-06-19
EP0750037A3 (de) 1997-01-15
EP0491878B1 (de) 1997-02-19
ES2097766T3 (es) 1997-04-16
AU5940090A (en) 1991-04-03
EP0491878A1 (de) 1992-07-01
DE69029970D1 (de) 1997-03-27
CA2020700A1 (en) 1991-02-17
JP2930713B2 (ja) 1999-08-03
DK0491878T3 (da) 1997-06-23
EP0750037A2 (de) 1996-12-27
WO1991002540A1 (en) 1991-03-07
JPH04507044A (ja) 1992-12-10
AU685609B2 (en) 1998-01-22
AU2047495A (en) 1995-10-19

Similar Documents

Publication Publication Date Title
ATE148992T1 (de) Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
FI20000507A (fi) (+)-1-(3-dimetyyliaminopropyyli)-1-(4'-fluorifenyyli)-1,3-dihydroisobentsofuraani-5-karbonitriili ja sitä sisältävä farmaseuttinen koostumus
DE69427017T2 (de) Herstellung von 3,4,4-trisubstituiertem Piperidinyl-n-alkylcarboxylaten und Zwischenverbindungen, verwendbar als opioid Antagonisten
DK15589D0 (da) Kemiske forbindelser
ATE133556T1 (de) Aminosäure-beta-lyase-enzyminhibitoren als deodorantien
ATE144498T1 (de) Herstellung von substituierten piperidinen
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
DE68902192T2 (de) Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen.
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69022491D1 (de) Herstellung von Tertiär-Kohlenwasserstoff-Silyl-Verbindungen.
DE69402441D1 (de) Neue 17,20-Epoxyd Derivate von Pregnan, ihre Verwendung zur Herstellung von Cortison-Derivaten und Zwischenprodukte dafür
DE69811810D1 (de) Zusammensetzung auf Basis von verdünntem Meerwasser zur Behandlung der nasalen Fossae
FI921356A0 (fi) Somatostatinreceptor.
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
ATE47782T1 (de) Koeder in granulatform zur bekaempfung von ameisen.
DE69204497T2 (de) Verfahren und Zwischenprodukte zur Herstellung von 2,2-Dimethyl-2,3-Dihydrobenzofuran-7-Carbonsäuren.
DE59309818D1 (de) Verfahren zur Herstellung von 2,6-Dimethylmorpholin aus N-(2-Hydroxypropyl)-2,6-dimethylmorpholin
DE3881683T2 (de) Zusammenstellung und verfahren zur oxydierenden umwandlung von organischen verbindungen unter verwendung derselben.
DE69200487D1 (de) Verfahren zur Herstellung von Kautschukzusammensetzungen.